What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Travel Medicine"
DOI: 10.1093/jtm/taab026
Abstract: Given China’s relatively weak innovative and regulatory capacity compared with developed countries, China’s progress on COVID-19 vaccines is especially impressive. We summarize three key lessons from China’s experience with COVID-19 vaccine R&D: (i) set strategic… read more here.
Keywords: china discussion; discussion public; covid vaccine; learn covid ... See more keywords